In an announcement today from the Foundation Fighting Blindness, and confirmed by Oxford BioMedica, the Casey Eye Institute of the Oregan Health & Science University (OHSU) is preparing to treat the first Usher Syndrome patient under the clinical protocol designed by Oxford BioMedica using its UshStat gene therapy treatment.
(For more information about this study, please see my Update 1: First Clinical Trial for a Form of Retinitis Pigmentosa (RP) Approved to Begin)
Here is the complete text of the FFB news release:
March 6, 2012 - The first-ever (Read more...)